-
Maternal serum cytokines at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Poon LC, Bansal AS, Nicolaides KH.
Prenat Diagn 2013;33:823-30. pdf -
Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013;26:763-7. -
Systolic, diastolic and mean arterial pressure at 30-33 weeks in the prediction of preeclampsia.
Lai J, Poon LC, Bakalis S, Chiriac R, Nicolaides KH.
Fetal Diagn Ther 2013;33:173-81. -
Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia.
Lai J, Pinas A, Poon LC, Agathokleous M, Nicolaides KH.
Fetal Diagn Ther 2013;33:164-72. -
Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia.
Lai J, Poon LC, Pinas A, Bakalis S, Nicolaides KH.
Fetal Diagn Ther 2013;33:156-63. -
Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH.
Fetal Diagn Ther 2013;33:149-55. -
Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013;26:733-7. -
Maternal arterial stiffness in women who subsequently develop pre-eclampsia.
Savvidou MD, Kaihura C, Anderson JM, Nicolaides KH.
PLoS One 2011;6:e18703. -
Association of placental volume measured by MRI and birth weight percentile.
Derwig IE, Akolekar R, Zelaya FO, Gowland PA, Barker GJ, Nicolaides KH.
J Magn Reson Imaging 2011;34:1125-30. -
Maternal arterial stiffness in pregnancies affected by pre-eclampsia.
Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH.
Am J Physiol Heart Circ Physiol 2009;297:759-64. -
Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations.
Akbar SA, Khawaja NP, Brown PR, Tayyeb R, Bamfo J, Nicolaides KH.
Acta Obstet Gynecol Scand 2009;88:606-11. -
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:871-6. -
Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:682-6. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls.
Albrecht C, Soumian S, Tetlow N, Patel P, Sullivan MH, Lakasing L, Nicolaides K, Williamson C.
Placenta 2007;28:701-8. -
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.
Yu CKh, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD.
BMC Pregnancy Childbirth 2006;6:7. -
Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:658-63. -
Can aneroid sphygmomanometers be used at altitude?
Kametas NA, McAuliffe F, Krampl E, Nicolaides KH, Shennan AH.
J Hum Hypertens 2006;20:517-22. -
An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.
Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH.
Am J Obstet Gynecol 2005;193:429-36. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61.